These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 16554296)
1. CpG DNA-mediated induction of acute liver injury in D-galactosamine-sensitized mice: the mitochondrial apoptotic pathway-dependent death of hepatocytes. Yi AK; Yoon H; Park JE; Kim BS; Kim HJ; Martinez-Hernandez A J Biol Chem; 2006 May; 281(21):15001-12. PubMed ID: 16554296 [TBL] [Abstract][Full Text] [Related]
2. CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases. Kim YI; Park JE; Martinez-Hernandez A; Yi AK J Biol Chem; 2008 May; 283(22):15258-70. PubMed ID: 18378686 [TBL] [Abstract][Full Text] [Related]
3. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277 [TBL] [Abstract][Full Text] [Related]
4. Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. Lin BR; Yu CJ; Chen WC; Lee HS; Chang HM; Lee YC; Chien CT; Chen CF J Biomed Sci; 2009 Mar; 16(1):35. PubMed ID: 19317920 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice. Dejager L; Libert C Cytokine; 2008 Apr; 42(1):55-61. PubMed ID: 18331798 [TBL] [Abstract][Full Text] [Related]
6. Caspase activation during hepatocyte apoptosis induced by tumor necrosis factor-alpha in galactosamine-sensitized mice. Osawa Y; Banno Y; Nagaki M; Nozawa Y; Moriwaki H; Nakashima S Liver; 2001 Oct; 21(5):309-19. PubMed ID: 11589767 [TBL] [Abstract][Full Text] [Related]
7. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533 [TBL] [Abstract][Full Text] [Related]
8. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine. Endo Y; Kikuchi T; Nakamura M Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Amir M; Zhao E; Fontana L; Rosenberg H; Tanaka K; Gao G; Czaja MJ Cell Death Differ; 2013 Jul; 20(7):878-87. PubMed ID: 23519075 [TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Wang H; Xu DX; Lu JW; Zhao L; Zhang C; Wei W Acta Pharmacol Sin; 2007 Nov; 28(11):1803-9. PubMed ID: 17959032 [TBL] [Abstract][Full Text] [Related]
11. Possible involvement of reactive oxygen species in D-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. Osawa Y; Nagaki M; Banno Y; Yamada Y; Imose M; Nozawa Y; Moriwaki H; Nakashima S J Cell Physiol; 2001 Jun; 187(3):374-85. PubMed ID: 11319761 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure. Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692 [TBL] [Abstract][Full Text] [Related]
13. The effect of Z-FA.FMK on D-galactosamine/TNF-alpha-induced liver injury in mice. Gezginci S; Bolkent S Cell Biochem Funct; 2007; 25(3):277-86. PubMed ID: 16850524 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages. Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250 [TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor-alpha and nitric oxide mediate apoptosis by D-galactosamine in a primary culture of rat hepatocytes: exacerbation of cell death by cocultured Kupffer cells. Abou-Elella AM; Siendones E; Padillo J; Montero JL; De la Mata M; Muntané Relat J Can J Gastroenterol; 2002 Nov; 16(11):791-9. PubMed ID: 12464973 [TBL] [Abstract][Full Text] [Related]
16. Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Künstle G; Hentze H; Germann PG; Tiegs G; Meergans T; Wendel A Hepatology; 1999 Nov; 30(5):1241-51. PubMed ID: 10534346 [TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice. Wang H; Xu DX; Lv JW; Ning H; Wei W Toxicology; 2007 Jul; 237(1-3):49-57. PubMed ID: 17602819 [TBL] [Abstract][Full Text] [Related]
18. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation. Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915 [TBL] [Abstract][Full Text] [Related]
19. Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment. Seki R J Immunol Res; 2017; 2017():9653793. PubMed ID: 29181417 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Nagaki M; Naiki T; Brenner DA; Osawa Y; Imose M; Hayashi H; Banno Y; Nakashima S; Moriwaki H Hepatology; 2000 Dec; 32(6):1272-9. PubMed ID: 11093734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]